Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Orthopaedics
Published in: International Orthopaedics 6/2013

Open Access 01-06-2013 | Original Paper

Effect of implanted bisphosphonate-enriched cement on the trabecular microarchitecture of bone in a rat model using micro-computed tomography

Authors: Łukasz Matuszewski, Karolina Turżańska, Anna Matuszewska, Mirosław Jabłoński, Izabela Polkowska, Tomasz Mazurkiewicz

Published in: International Orthopaedics | Issue 6/2013

Login to get access

Abstract

Purpose

Bisphosphonates (BPs) are antiresorptive drugs typically used to inhibit bone resorption. The latest reports show that BPs play an important role in not only achieving better bone mineral density but also in improving bone microarchitecture. The mechanism of action of the BPs is complex and multifactorial. We tried to determine whether there are any changes in the microarchitectural bone structure during local use of BP (Pamifos 60). The aim of this study was to see if BP-enriched cement used in rat models had positive effects on bone formation.

Methods

Research was performed on 40 adult male Wistar rats that were divided into four groups: two control groups and two experimental groups. Rats in the experimental groups were implanted with BP-enriched cement into the bone, while the control group rats were implanted with clean bone cement (without BP). Micro-computed tomography was applied for the investigation of trabecular microarchitecture of the proximal physis of the tibial bone in all animals three and six weeks after surgery. In all microCT images variables such as bone volume density (BV/TV), trabecular thickness (TbTh), trabecular separation (TbSp) and trabecular number (TbN) were used to describe trabecular bone morphometry.

Results

The major finding of this study is that using BP-enriched cement results in distinct changes in bone microarchitecture. We showed that local use of pamidronate (Pamifos 60) in orthopaedic cement had a positive effect on bone formation. It significantly changed three variables. We noticed increasing bone volume fraction and trabecular thickness together with decreasing trabecular separation.

Conclusion

In this paper we demonstrate the efficacy of using BP-enriched cement in vitro in the tibiae of rats. Our most significant finding based on micro-CT picture analysis allows us to start further work on more suitable applications of BP-enriched cement in humans. We believe that future successful experiments will facilitate potential use of BP-enriched cement in clinical applications.
Literature
1.
Bock O, Börst H, Beller G, Armbrecht G, Degner C, Martus P, Roth HJ, Felsenberg D (2012) Impact of oral ibandronate 150 mg once monthly on bone structure and density in post-menopausal osteoporosis or osteopenia derived from in vivo μCT. Bone 50(1):317–324PubMedCrossRef
2.
Geoffroy V, Paschalis EP, Libouban H, Blouin S, Ostertag A, Chappard D, Cros M, Phipps R, de Vernejoul MC (2011) Effects of risedronate in Runx2 overexpressing mice, an animal model for evaluation of treatment effects on bone quality and fractures. Calcif Tissue Int 88(6):464–475PubMedCrossRef
3.
Reinholz GG, Getz B, Pederson L, Sanders ES, Subramaniam M, Ingle JN, Spelsberg TC (2000) Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts. Cancer Res 60:6001–6007PubMed
4.
Giuliani N, Pedrazzoni M, Negri G, Passeri G, Impicciatore M, Girasole G (1998) Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo. Bone 22:455–461PubMedCrossRef
5.
Sahni M, Guenther HL, Fleisch H, Collin P, Martin TJ (1993) Bisphosphonates act on rat bone resorption through the mediation of osteoblasts. J Clin Invest 91:2004–2011PubMedCrossRef
6.
Fleisch H (1998) Bisphosphonates: mechanisms of action. Endcr Rev 19:80–100CrossRef
7.
Russell RGG, Rogers MJ (1999) Bisphosphonates: from the laboratory to the clinic and back again. Bone 25:97–106PubMedCrossRef
8.
9.
Douglas DL, Russell RGG, Kanis JA, Preston CJ, Preston FE, Preston MA, Woodhead JS (1980) Effect of dichloromethylene diphosphonate in Paget’s disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignat disease. Lancet 1:10443–11047
10.
11.
Watts NB, Harris ST, Genant HK, Wasnich RD, Miller PD, Jackson RD, Licata AA, Ross P, Woodson GC, Yanover MJ, Mysiw WJ, Kohse L, Rao MB, Steiger P, Richmond B, Chesnut CH (1990) Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 323:73–79PubMedCrossRef
12.
Kellinsalmi M, Monkkonen H, Monkkonen J et al (2005) In vitro comparison of clodronate, pamidronate, and zoledronic acid effects on rat osteoclast and human stem cell-derived osteoblasts. Basic Clin Pharmacol Toxicol 97:382–391PubMedCrossRef
13.
Plotkin LI, Manolagas SC, Bellido T (2006) Dissociation of the pro-apoptocic effects of bisphosphonates on osteoclasts from their anti-apoptotic effects on osteoblasts/osteocyters with novel analogs. Bone 39:443–452PubMedCrossRef
14.
Peter B, Gauthier O, Laib S, Bujoli B, Guicheux J, Janvier P et al (2006) Local delivery of bisphosphonate from coated orthopedic implants increases implant mechanical stability in osteoporotic rats. J Biomed Mater Res A 76:133–143PubMed
15.
Agholme F, Aspenberg P (2009) Experimental results of combing bisphosphonates with allograft in a rat model. J Bone Joint Surg Br 91-B:670–675CrossRef
16.
17.
Dempster DW, Compston JE, Drezner MK, Glorieux FH, Kanis A, Malluche H, Meunier PJ, Ott SM, Recker RR, Parfitt MA (2013) Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 28(1):2–17PubMedCrossRef
18.
Xuenong Z, Qingyun X, Haishengen L, Bunger M, Lind M, Bunger C (2003) Effect of alendronate on bone ingrowth into porous tantalum and carbon fiber interbody devices. Acta Orthop Scand 74(5):596–603CrossRef
19.
Aspenberg A, Astrand J (2002) Bone allograft pretreated with bisphosphonate are not resorbed. Acta Ortop Scand 73(1):20–23CrossRef
20.
Jee JH, Lee W, Lee BD (2010) The influence of alendronate on the healing of extraction sockets of ovariectomized rats assessed by in vivo microcomputed tomography. Oral Surg, Oral Med, Oral Pathol, Oral Radiol Endodontol 110(2):47–53CrossRef
21.
Jones MD, Tran CW, Li G, Maksymowych WP, Zernicke RF, Doschak MR (2010) In vivo microfocal computed tomography and micro-magnetic resonance imaging evaluation of antiresorptive and antiinflammatory drugs as preventive treatments of osteoarthritis in the rat. Arthritis Rheum 62(9):2726–2735PubMedCrossRef
22.
Allen MR (2011) The effects of bisphosphonates on jaw bone remodeling, tissue properties, and extraction healing. Odontology 99(1):8–17PubMedCrossRef
23.
Schindeler A, Birke O, Yu NY, Morse A, Ruys A, Baldock PA, Little DG (2011) Distal tibial fracture repair in a neurofibromatosis type 1-deficient mouse treated with recombinant bone morphogenetic protein and a bisphosphonate. J Bone Joint Surg Br 93(8):1134–1139PubMed
24.
Qi M, Hu J, Li J, Li J, Dong W, Feng X, Yu J (2012) Effect of zoledronate acid treatment on osseointegration and fixation of implants in autologous iliac bone grafts in ovariectomized rabbits. Bone 50(1):119–127PubMedCrossRef
25.
Jakobsen T, Bass J, Bechtold JE, Elmengaard B, Soballe K (2007) Soaking morselized allograft bone in bisphosphonate can impair implant fixation. Clin Orthop 463:195–201PubMed
26.
Baas J, Elmengaard B, Jensen TB et al (2005) The effect of pretreating morselized allograft bone with rhBMP-2 and/or pamidronate on the fixation of porous Ti and HA coated implants. Biomaterials 29:2915–2922CrossRef
27.
Seeman E, Delmas PD, Hanley DA, Sellmeyer D, Cheung AM, Shane E, Kearns A, Thomas T, Boyd SK, Boutroy S, Bogado C, Majumdar S, Fan M, Libanati C, Zanchetta J (2010) Microarchitectural deterioration of cortical and trabecular bone: differing effects of denosumab and alendronate. J Bone Miner Res 25(8):1886–1894PubMedCrossRef
28.
Gao Y, Zou S, Liu X, Bao C, Jing H (2009) The effect of surface immobilized bisphosphonates on the fixation of hydroxyapatite-coated titanium implants in ovariectomized rats. Biomaterials 30:1790–1796PubMedCrossRef
29.
Ward LM, Petryk A, Gordon C (2009) Use of bisphosphonates in treatment of pediatric osteoporosis. Int J Clin Rheumatol 4(6):657–672CrossRef
30.
Glowacki J, Hurwitz S, Thornhill TS, Kelly M, LeBoff MS (2003) Osteoporosis and vitamin-D deficiency among posmenopausal women with osteoarthritis undergoing total hip arthroplasty. J Bone Joint Surg Am 85:2371–2377PubMed
31.
Wermelin K, Suska F, Tengvall P, Thomsen P, Spenberg P (2008) Stainless steel screws with bisphosphonates gave stronger fixation and more surrounding bone. Histomorphometry in rats. Bone 42:365–371PubMedCrossRef
32.
Youshinari M, Oda Y, Ueki H, Yokose S (2002) Immobilization of bisphosphonates on surface modified titanium. Biomaterials 23:2870–2885
33.
Youshinari M, Oda Y, Inoue T, Matsuzaka T, Shimono M (2001) Bone response to calcium phosphate-coated and bisphosphonates-immobilized titanium implants. Biomaterials 22:709–715CrossRef
34.
Tanzer M, Karabasz D, Krygier JJ, Cohen R, Bobyn JD (2005) Bone augmentation around and within porosus implants by local bisphosphonates elution. Clin Orthop Relat Res 441:30–39PubMedCrossRef
35.
Kajiwara H, Yamaza T, Yoshinari M, Goto T, Iyama S, Atsuta I et al (2005) The bisphosphonate pamidronate on the surface of titanium stimulates bone formation around tibial implants in rats. Biomaterials 26:581–587PubMedCrossRef
36.
Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced a vascular necrosis of the jaw: a growing epidemic. J Oral Maxillofac Surg 61:1115–1117PubMedCrossRef
37.
Metadata
Title
Effect of implanted bisphosphonate-enriched cement on the trabecular microarchitecture of bone in a rat model using micro-computed tomography
Authors
Łukasz Matuszewski
Karolina Turżańska
Anna Matuszewska
Mirosław Jabłoński
Izabela Polkowska
Tomasz Mazurkiewicz
Publication date
01-06-2013
Publisher
Springer-Verlag
Published in
International Orthopaedics / Issue 6/2013
Print ISSN: 0341-2695
Electronic ISSN: 1432-5195
DOI
https://doi.org/10.1007/s00264-013-1855-z

Other articles of this Issue 6/2013

International Orthopaedics 6/2013 Go to the issue

Original Paper

Posterior acetabular arc angle of the femoral head assesses instability of posterior fracture-dislocation of the hip

Original Paper

Navicular index for differentiation of flatfoot from normal foot

Original Paper

Can patients return to high-impact physical activities after hip resurfacing? A prospective study

Original Paper

Boomerang proximal tibial osteotomy for the treatment of severe varus gonarthrosis

Original Paper

Dose- and time-dependent effect of high glucose concentration on viability of notochordal cells and expression of matrix degrading and fibrotic enzymes

Letter to the Editor

Reply to: Can we decipher the indications and outcome of the PHILOS plate for fractures of the proximal humerus?